Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by tuesdaynightridon Nov 24, 2014 5:05pm

271 Views

Post# 23159732

News Release and Ngamia Quote

I go away for 24 hours and TLT has actually moved up the bladder cancer trial timeline per original 2014 timeline (is this the correct excerpt or did he actually mean 2015)?? Mr. Dumoulin-White went on to say, "Our patented cancer technology is demonstrating significant success in the pre-clinical stages and is on track for clinical evaluation in humans for bladder cancer in late 2014. Ngamia, did I read your quote correctly? Did you really post this? "And Yes! bigger mammmals is nothing more than stupid!"... now that's a true classic!

Bullboard Posts

Rising miner increases graphite price, restarts Québec mill